Goepper Burkhardt’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Hold
396
0.14% 66
2026
Q1
$364K Buy
396
+32
+9% +$32.4K 0.12% 73
2025
Q4
$391K Hold
364
0.13% 71
2025
Q3
$278K Hold
364
0.09% 83
2025
Q2
$284K Buy
364
+27
+8% +$21K 0.1% 79
2025
Q1
$278K Buy
337
+23
+7% +$19.1K 0.11% 80
2024
Q4
$242K Sell
314
-12
-4% -$9.94K 0.1% 75
2024
Q3
$289K Hold
326
0.12% 66
2024
Q2
$295K Sell
326
-2
-0.6% -$1.6K 0.13% 65
2024
Q1
$249K Buy
328
+16
+5% +$11.4K 0.12% 72
2023
Q4
$231K Buy
+312
New +$182K 0.11% 72

Other funds holding LLY

Goepper Burkhardt's LLY Position: Q2 2026 in Review

Goepper Burkhardt held its Eli Lilly (LLY) position steady in Q2 2026 at 396 shares worth $475K. The position accounts for 0.14% of the portfolio, ranked #66.

Goepper Burkhardt first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Goepper Burkhardt held 396 shares of Eli Lilly worth $475K as of Q2 2026.
  • Goepper Burkhardt left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.14% of Goepper Burkhardt's portfolio in Q2 2026, its #66 holding.
  • Goepper Burkhardt first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Goepper Burkhardt's 13F filing for Q2 2026, filed 10 Aug 2026.